Skip to main content
Knowledge & Perspective

Ragupathy Pharma Insights

Stay updated with curated pharmaceutical industry insights, regulatory developments, emerging technologies, market trends, career opportunities, and professional perspectives from Ragupathy Renganathan. Designed to help students, professionals, and industry leaders stay informed in a rapidly evolving pharmaceutical landscape.

Curated by Ragupathy Renganathan · 18+ Years in Pharma · Practical Pharma Knowledge & Industry Insights

Clinical Trial Blinding
Clinical Research

Clinical Trial Blinding

Clinical Trial Blinding explains how blinding reduces bias and strengthens the reliability of clinical research. This guide covers types of blinding, its importance in randomized clinical trials, practical challenges, ethical considerations, and its relevance to Pharm D students and clinical research professionals.

8/12/202615 min
The AI-Driven Pharmaceutical Workforce: Which Pharma Jobs Will Change First?
Career Growth & Digital Skills

The AI-Driven Pharmaceutical Workforce: Which Pharma Jobs Will Change First?

AI is transforming pharmaceutical workflows across drug development, quality, regulatory affairs, pharmacovigilance, clinical research and manufacturing. Explore which pharma jobs are likely to change first and how professionals can build the scientific, digital and AI capabilities needed to remain valuable in the evolving pharmaceutical workforce.

8/6/202615 min
Artificial Intelligence Applications in Pharmacovigilance Operations
Pharmacovigilance

Artificial Intelligence Applications in Pharmacovigilance Operations

Discover how Artificial Intelligence is transforming pharmacovigilance operations through automated case processing, signal detection, literature surveillance, aggregate safety reporting, and predictive analytics. Learn how AI enhances regulatory compliance, operational efficiency, and patient safety across the pharmaceutical industry.

7/24/202615 min
Aggregate Safety Reports: PBRER, PSUR, and DSUR Explained
Pharmacovigilance

Aggregate Safety Reports: PBRER, PSUR, and DSUR Explained

Learn the differences between PBRER, PSUR, and DSUR and understand how aggregate safety reports support benefit-risk evaluation, regulatory compliance, and global pharmacovigilance throughout a medicinal product's lifecycle.

7/22/202615 min
Strategic Product Selection for Generic Pharmaceutical Companies
Pharma Business Development

Strategic Product Selection for Generic Pharmaceutical Companies

Strategic product selection is one of the most critical decisions influencing the success of generic pharmaceutical companies. This article explores how pharmaceutical leaders evaluate market opportunities, competitive landscapes, regulatory pathways, manufacturing capabilities, and portfolio strategies to identify profitable generic products while minimising development risks and maximising long-term business growth.

7/20/202615 min
10 Questions Every Pharma Company Should Ask Before Choosing a Manufacturing Partner
Production

10 Questions Every Pharma Company Should Ask Before Choosing a Manufacturing Partner

Choosing the right pharmaceutical manufacturing partner is a critical decision that impacts product quality, regulatory approval, supply chain reliability, and business growth. Explore the 10 essential questions every pharma company should ask before selecting a CMO or CDMO partner for successful long-term collaboration.

7/18/202615 min
Understanding Market Exclusivity and Patent Strategy
Intellectual Property Rights

Understanding Market Exclusivity and Patent Strategy

Explore how market exclusivity and patent strategy shape pharmaceutical innovation, regulatory success, lifecycle management, and long-term commercial growth.

7/15/202615 min
How Predictive Analytics is Transforming Pharmaceutical Supply Chain Risk Management
Supply Chain

How Predictive Analytics is Transforming Pharmaceutical Supply Chain Risk Management

Predictive analytics is enabling pharmaceutical companies to anticipate disruptions, optimize inventory, and strengthen supply chain resilience through data-driven decision-making. This article explores how advanced analytics is transforming risk management across the global pharmaceutical supply chain.

7/2/202610 min
The Growing Role of AI Copilots in Regulatory Affairs and Medical Writing
Regulatory Affairs

The Growing Role of AI Copilots in Regulatory Affairs and Medical Writing

AI copilots are transforming regulatory affairs and medical writing by accelerating document creation, improving accuracy, and supporting faster regulatory submissions. This article explores how AI is enhancing productivity while maintaining compliance and scientific quality in the pharmaceutical industry.

6/21/202610 min
Free Subscription

Get Pharma Insights in your inbox

Free updates on regulatory developments, market trends, and professional perspectives.